|
|
|
|
| LEADER |
01210nab a2200313 i 4500 |
| 001 |
publ3104 |
| 005 |
20180713084000.0 |
| 008 |
130531s2012 hu o 0|| zxx d |
| 022 |
|
|
|a 1535-7163
|
| 024 |
7 |
|
|a 10.1158/1535-7163.MCT-11-0921
|2 doi
|
| 024 |
7 |
|
|a 2047292
|2 mtmt
|
| 040 |
|
|
|a SZTE Publicatio Repozitórium
|b hun
|
| 041 |
|
|
|a zxx
|
| 100 |
1 |
|
|a Wang Hui-Chun
|
| 245 |
1 |
0 |
|a Inhibition of ATR-dependent signaling by protoapigenone and its derivative sensitizes cancer cells to interstrand cross-link–generating agents in vitro and in vivo
|h [elektronikus dokumentum] /
|c Wang Hui-Chun
|
| 260 |
|
|
|a American Association for Cancer Research
|c 2012
|
| 300 |
|
|
|a 1443-1453
|
| 490 |
0 |
|
|a Molecular Cancer Therapeutics
|v 11 No. 7
|
| 700 |
0 |
1 |
|a Lee Alan Yueh-Luen
|e aut
|
| 700 |
0 |
1 |
|a Chou Wen-Cheng
|e aut
|
| 700 |
0 |
1 |
|a Wu Chin-Chung
|e aut
|
| 700 |
0 |
1 |
|a Tseng Chao-Neng
|e aut
|
| 700 |
0 |
1 |
|a Liu Kevin Yen-Ting
|e aut
|
| 700 |
0 |
1 |
|a Lin Wen-Lien
|e aut
|
| 700 |
0 |
1 |
|a Chang Fang-Rong
|e aut
|
| 700 |
0 |
1 |
|a Chuang Da-Wei
|e aut
|
| 700 |
0 |
1 |
|a Hunyadi Attila
|e aut
|
| 700 |
0 |
1 |
|a Wu Yang-Chang
|e aut
|
| 856 |
4 |
0 |
|u http://publicatio.bibl.u-szeged.hu/3104/1/2047292%20Wang%20et%20al%20Mol%20Cancer%20Ther_2012.pdf
|z Dokumentum-elérés
|